BYETTA is a non-insulin type 2 diabetes injection medication for adults. Learn about BYETTA, the BYETTA Pen. in patients with prior severe hypersensitivity reactions to exenatide or to any of the product components. Patient Information Leaflet. Package leaflet: Information for the patient. Byetta 5 micrograms solution for injection in pre-filled pen. Byetta 10 micrograms solution .
|Published (Last):||19 September 2015|
|PDF File Size:||15.22 Mb|
|ePub File Size:||15.94 Mb|
|Price:||Free* [*Free Regsitration Required]|
BYETTA should not be used in people with type 1 diabetes or people with diabetic ketoacidosis a condition caused by very high blood sugar.
No placebo-treated patients withdrew due to nausea or vomiting. Staying Active Learn how regular physical activity can help you manage type 2 diabetes. Tell your healthcare provider if you have severe problems with your stomach, such as delayed emptying of your stomach gastroparesis or problems with digesting food.
Welcome to BYETTA.com!
Inflammation of the pancreas pancreatitis may happen, which may be severe and lead to death. If pancreatitis is suspected, BYETTA should be discontinued promptly and should not be restarted if pancreatitis is confirmed. Postmarketing reports of altered renal function, including increased serum creatinine, renal impairment, worsened chronic renal failure, and acute renal failure, sometimes requiring hemodialysis and kidney transplantation.
After initiation and dose increases of BYETTA, observe patients carefully for pancreatitis including persistent severe abdominal pain, sometimes radiating to the back, with or without vomiting. Use with caution in patients with renal transplantation or when initiating or escalating the dose in patients with moderate renal failure.
Use in pediatric patients is not recommended as safety and effectiveness have not been established. Talk to your healthcare provider first if you are breastfeeding or plan to breastfeed.
Drug Interactions Oral Medications: Oral medications dependent on threshold concentrations for efficacy, such as contraceptives or antibiotics, should be taken at least 1 hour before BYETTA.
Based on animal data, BYETTA may cause fetal harm and should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
To report drug exposure during pregnancy call Increased risk of hypoglycemia when used in combination with a sulfonylurea SU or when used with a glucose-independent insulin secretagogues eg, meglitinides. Your risk for getting low blood sugar hypoglycemia is higher if you take BYETTA with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin.
It is unknown whether patients with a history of pancreatitis are at increased risk for pancreatitis while using BYETTA; consider other antidiabetic therapies paclage these inssrt.
Official BYETTA® (exenatide) injection Healthcare Professional Website
This product information is intended for US Healthcare Professionals only. Should not be used in patients with severe renal impairment or end-stage renal disease. Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritability, hunger, fast heartbeat, sweating, and feeling jittery. If worsening of or failure to achieve adequate glycemic control occurs, consider packzge antidiabetic therapy.
Add BYETTA to insulin glargine as a complementary action to help improve glycemic control
These may be symptoms of pancreatitis. Approved Uses BYETTA is an injectable prescription medicine that may improve blood sugar glucose control in adults with type 2 diabetes, when used with diet and exercise.
BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or packge pancreatitis, based on postmarketing data. Go to Healthcare Byetta Site. Call your healthcare provider right away if you have nausea, vomiting, or diarrhea that will not go away, or if you cannot take liquids by mouth.
Based on postmarketing data BYETTA has been associated with acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis. The most common side effects with BYETTA include nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, acid stomach, constipation, and weakness.
Write your html here All other trademarks are property of their respective owners. All other trademarks are property of their respective owners.
Not a substitute for insulin and should not be used in patients with type 1 diabetes or diabetic ketoacidosis.